Shipment of delandistrogene moxeparvovec, a gene therapy for Duchenne muscular dystrophy (DMD), will resume following a ...

But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...

His stringent oversight of biopharmaceutical company Sarepta Therapeutics' gene therapy for Duchenne Muscular Dystrophy (DMD) ...